FDA Clears Wireless Maternal-Fetal Monitoring Platform
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The cleared system introduces photon-counting CT designed to capture spectral data in a single scan and reduce protocol complexity.
The system features a compact footprint and is designed for whole-body imaging in neonatal care settings.
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The platform uses a closed helium circuit and AI-based workflows to reduce helium use, energy consumption, and exam time.
Read MoreThe system is designed to give surgeons a clear, real-time view of critical anatomy and planned trajectories.
Read MoreNew guidance permits the use of de-identified data without requiring individual patient information in marketing submissions.
Read MoreThe system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy.
Read MoreThe platform’s 510(k) clearance adds PET-CT workflows—including SUV quantification, fusion, MIP, and MPR—to its browser-based diagnostic environment, advancing unified cloud imaging infrastructure.
Read MoreThe clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
Read More
The no-capital-expenditure ultrasound platform is designed to simplify workflow, reduce cost, and enhance procedural efficiency inside the cath lab.